Journal of Pediatric Epilepsy 2016; 05(04): 153-158
DOI: 10.1055/s-0036-1584916
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Pediatric Epilepsy: A “Histo”-Pathologic Perspective

Seema Shroff
1   Department of Pathology, Center for Diagnostic Pathology, Florida Hospital, Florida, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

18. Januar 2016

16. Februar 2016

Publikationsdatum:
25. Juli 2016 (online)

Abstract

Mankind has pondered over the nature of epilepsy for centuries and this review provides a historical perspective of the evolution of that thought process with particular regard to pathophysiology, neuropathology and etiology. In light of the diversity of the etiologies briefly discussed here, it follows naturally that treatment modalities and management varies in different situations, more so in the pediatric setting. This review presents an overview of decades of laboratory work that has culminated in a widely accepted, clinically relevant pathologic classification with prognostic and therapeutic implications, particularly for focal cortical dysplasias. It also showcases some of the recent discoveries using cutting edge molecular methods that will eventually lead to better diagnosis and management of this condition.

 
  • References

  • 1 Shorvon SD. The causes of epilepsy: changing concepts of etiology of epilepsy over the past 150 years. Epilepsia 2011; 52 (6) 1033-1044
  • 2 Lindsay J, Ounsted C, Richards P. Long-term outcome in children with temporal lobe seizures. V: Indications and contra-indications for neurosurgery. Dev Med Child Neurol 1984; 26 (1) 25-32
  • 3 Jehi L, Friedman D, Carlson C , et al. The evolution of epilepsy surgery between 1991 and 2011 in nine major epilepsy centers across the United States, Germany, and Australia. Epilepsia 2015; 56 (10) 1526-1533
  • 4 Green RC, Adler JR, Erba G. Epilepsy surgery in children. J Child Neurol 1988; 3 (3) 155-166
  • 5 Blümcke I, Spreafico R. Cause matters: a neuropathological challenge to human epilepsies. Brain Pathol 2012; 22 (3) 347-349
  • 6 Blumcke I, Cross JH, Spreafico R. The international consensus classification for hippocampal sclerosis: an important step towards accurate prognosis. Lancet Neurol 2013; 12 (9) 844-846
  • 7 Meencke HJ, Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984; 25 (1) 8-21
  • 8 Barth PG. Disorders of neuronal migration. Can J Neurol Sci 1987; 14 (1) 1-16
  • 9 Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. Classification system for malformations of cortical development: update 2001. Neurology 2001; 57 (12) 2168-2178
  • 10 Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971; 34 (4) 369-387
  • 11 Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995; 54 (2) 137-153
  • 12 Palmini A, Najm I, Avanzini G , et al. Terminology and classification of the cortical dysplasias. Neurology 2004; 62 (6) (Suppl. 03) S2-S8
  • 13 Majores M, Blümcke I, Urbach H , et al. Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells. J Neuropathol Exp Neurol 2005; 64 (7) 629-637
  • 14 Blümcke I, Vinters HV, Armstrong D, Aronica E, Thom M, Spreafico R. Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord 2009; 11 (3) 181-193
  • 15 Fauser S, Schulze-Bonhage A, Honegger J , et al. Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain 2004; 127 (Pt 11) 2406-2418
  • 16 Hildebrandt M, Pieper T, Winkler P, Kolodziejczyk D, Holthausen H, Blümcke I. Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol 2005; 110 (1) 1-11
  • 17 Chamberlain WA, Cohen ML, Gyure KA , et al. Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Epilepsia 2009; 50 (12) 2593-2598
  • 18 Blümcke I, Thom M, Aronica E , et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52 (1) 158-174
  • 19 Prayson RA. Classification and pathological characteristics of the cortical dysplasias. Childs Nerv Syst 2014; 30 (11) 1805-1812
  • 20 Johnson AM, Sugo E, Barreto D , et al. Clinicopathological associations in temporal lobe epilepsy patients utilising the current ILAE focal cortical dysplasia classification. Epilepsy Res 2014; 108 (8) 1345-1351
  • 21 Ellison D, Love S, Chemilli L , et al. Neuropathology: A Reference Text of CNS Pathology. 3rd ed. London: Elsivier Mosby; 2013
  • 22 Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO Classification of Tumors of the Central Nervous System. 4th ed. Lyon: International Agency for Research on Cancer; 2007
  • 23 Jóźwiak S, Mandera M, Młynarski W. Natural history and current treatment options for subependymal giant cell astrocytoma in tuberous sclerosis complex. Semin Pediatr Neurol 2015; 22 (4) 274-281
  • 24 Barba C, Jacques T, Kahane P , et al. Epilepsy surgery in Neurofibromatosis Type 1. Epilepsy Res 2013; 105 (3) 384-395
  • 25 Drouet A. Seizures in neurofibromatosis. What is the risk? [in French]. Rev Neurol (Paris) 2011; 167 (12) 886-896
  • 26 Grabowski MM, Prayson RA. Focal cortical dysplasia in meningioangiomatosis. Clin Neuropathol 2015; 34 (2) 76-82
  • 27 Ottman R, Annegers JF, Hauser WA, Kurland LT. Seizure risk in offspring of parents with generalized versus partial epilepsy. Epilepsia 1989; 30 (2) 157-161
  • 28 Annegers JF, Hauser WA, Anderson VE, Kurland LT. The risks of seizure disorders among relatives of patients with childhood onset epilepsy. Neurology 1982; 32 (2) 174-179
  • 29 Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998; 43 (4) 435-445
  • 30 Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001; 68 (6) 1327-1332
  • 31 Helbig I, Mefford HC, Sharp AJ , et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009; 41 (2) 160-162
  • 32 Lalani SR, Zhang J, Schaaf CP , et al. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet 2014; 95 (5) 579-583
  • 33 Myers CT, Mefford HC. Advancing epilepsy genetics in the genomic era. Genome Med 2015; 7: 91 DOI: 10.1186/s13073-015-0214-7.
  • 34 Legido A, Katsetos CD. Experimental studies in epilepsy: immunologic and inflammatory mechanisms. Semin Pediatr Neurol 2014; 21 (3) 197-206
  • 35 Vezzani A, Fujinami RS, White HS , et al. Infections, inflammation and epilepsy. Acta Neuropathol 2016; 131 (2) 211-234
  • 36 Feindel W. Theodore Brown Rasmussen (1910-2002): epilepsy surgeon, scientist, and teacher. J Neurosurg 2003; 98 (3) 631-637
  • 37 Prayson RA. Dual pathology in Rasmussen's encephalitis: a report of coexistent focal cortical dysplasia and review of the literature. Case Rep Pathol 2012; 2012: 569170 DOI: 10.1155/2012/569170.